InvestorsHub Logo
Followers 160
Posts 1028
Boards Moderated 0
Alias Born 09/23/2013

Re: PaperLion post# 51547

Monday, 10/20/2014 9:59:03 AM

Monday, October 20, 2014 9:59:03 AM

Post# of 112592
paperlion, hemp is a close cousin of pot, they will...

still joined at the hip under a broader sector. its like w/ tech, do I buy business software or consumer app software stock plays.

It will benefit from another sustained pot rally, whether thats in fall or spring or later. there is way too many crossover uses (medicinal alone) for it not to do so. dscr is poised, if they execute their model to profit exponentially. i'd add the 5-10% cut looks to be significantly higher according to the hints in the financials.

most importantly, remember their business model didnt really start to converge until late spring-early summer. by that juncture most of the pot sector got taken down to near dec lows.

so what you have now is: a very undervalued, under the radar stock; a potential new star in a sector wh/ is soon to experience a 2nd wave of major investor attention; a stock w/ crucial health of canada immunity as the sec continues to beat down fraud shells in the sector as the sorting for new leadership occurs; & a company focused on the industrial and med side of the pot sector w/ hemp wh/ is ready to upramp as we speak... not a bad position to be in presently.